These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11426329)

  • 1. Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters.
    Velasco B; Ramírez JR; Relloso M; Li C; Kumar S; Lopez-Bote JP; Pérez-Barriocanal F; López-Novoa JM; Cowan PJ; d'Apice AJ; Bernabéu C
    Gene Ther; 2001 Jun; 8(12):897-904. PubMed ID: 11426329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gene expression to endothelium in transgenic animals: a comparison of the human ICAM-2, PECAM-1 and endoglin promoters.
    Cowan PJ; Shinkel TA; Fisicaro N; Godwin JW; Bernabéu C; Almendro N; Rius C; Lonie AJ; Nottle MB; Wigley PL; Paizis K; Pearse MJ; d'Apice AJ
    Xenotransplantation; 2003 May; 10(3):223-31. PubMed ID: 12694542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1.
    Ríus C; Smith JD; Almendro N; Langa C; Botella LM; Marchuk DA; Vary CP; Bernabéu C
    Blood; 1998 Dec; 92(12):4677-90. PubMed ID: 9845534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
    Azuma H
    J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
    Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
    J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia.
    Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M
    Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
    Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M
    Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality.
    Torsney E; Charlton R; Diamond AG; Burn J; Soames JV; Arthur HM
    Circulation; 2003 Apr; 107(12):1653-7. PubMed ID: 12668501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.
    Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M
    Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model of hereditary hemorrhagic telangiectasia.
    Bourdeau A; Dumont DJ; Letarte M
    J Clin Invest; 1999 Nov; 104(10):1343-51. PubMed ID: 10562296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
    Arthur HM; Ure J; Smith AJ; Renforth G; Wilson DI; Torsney E; Charlton R; Parums DV; Jowett T; Marchuk DA; Burn J; Diamond AG
    Dev Biol; 2000 Jan; 217(1):42-53. PubMed ID: 10625534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia.
    Argyriou L; Pfitzmann R; Wehner LE; Twelkemeyer S; Neuhaus P; Nayernia K; Engel W
    Liver Transpl; 2005 Sep; 11(9):1132-5. PubMed ID: 16123970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.
    Gallione CJ; Klaus DJ; Yeh EY; Stenzel TT; Xue Y; Anthony KB; McAllister KA; Baldwin MA; Berg JN; Lux A; Smith JD; Vary CP; Craigen WJ; Westermann CJ; Warner ML; Miller YE; Jackson CE; Guttmacher AE; Marchuk DA
    Hum Mutat; 1998; 11(4):286-94. PubMed ID: 9554745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective angiogenesis in mice lacking endoglin.
    Li DY; Sorensen LK; Brooke BS; Urness LD; Davis EC; Taylor DG; Boak BB; Wendel DP
    Science; 1999 May; 284(5419):1534-7. PubMed ID: 10348742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of normal and truncated forms of human endoglin.
    Raab U; Velasco B; Lastres P; Letamendía A; Calés C; Langa C; Tapia E; López-Bote JP; Páez E; Bernabéu C
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):579-88. PubMed ID: 10215596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1.
    Galaris G; Montagne K; Thalgott JH; Goujon GJPE; van den Driesche S; Martin S; Mager HJ; Mummery CL; Rabelink TJ; Lebrin F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.